 |
|
Fears about complications shouldn't drive antibiotic prescribing
October 19, 2007Antibiotics are not justified to reduce the risk of complications after upper respiratory tract infection, sore throat, or ear infection, finds a study published on bmj.com today
Antibiotics are not justified to reduce the risk of complications after upper respiratory tract infection, sore throat, or ear infection, finds a study published on bmj.com today.
But they do substantially cut the risk of pneumonia after chest infection, particularly in elderly people.
Most antibiotic prescribing is in primary care, and most of it is for common respiratory tract infections. Guidelines advise against the routine use of antibiotics in patients with upper respiratory tract infection, sore throat, and ear infection, but do recommend them for pneumonia.
Although rates of antibiotic prescribing for acute respiratory infections in UK general practice declined by 45% between 1994 and 2000, in 2000 antibiotics were still prescribed to 67% of patients with respiratory infection, including over 90% of those with chest infection, 80% with ear infections, 60% with sore throat, and 47% with upper respiratory tract infections.
On the basis of the evidence in this BMJ study, there seems to be a substantial gap between evidence based guidance and general practitioners' prescribing behaviour, say the authors.
So, they identified 3.36 million episodes of respiratory tract infection recorded between 1991 and 2001 in the UK General Practice Research Database and determined whether complications were less common in people who were prescribed antibiotics than in those who were not.
Risk of serious complications in the month after diagnosis were recorded: mastoiditis (infection of the mastoid bone of the skull) after ear infection, quinsy (an abscess at the back of the throat) after sore throat, and pneumonia after upper respiratory tract infection and chest infection.
The number of patients needed to treat to prevent one complication was also recorded.
Serious complications were rare after upper respiratory tract infections, sore throat, and ear infection. Antibiotics reduced the risk, but over 4,000 courses were needed to prevent one complication.
In contrast, the risk of pneumonia after chest infection was high, particularly in elderly people, and was substantially reduced by antibiotic use. The number needed to treat to prevent one case of pneumonia was 39 for those aged 65 and over and between 96 and 119 in younger age groups.
The risks were not appreciably different in smokers, those with chronic respiratory disease, or those with cardiac disease.
The authors conclude that general practitioners should not base their prescribing for sore throat, ear infection, or upper respiratory tract infections on a fear of serious complications. However, antibiotic prescribing to reduce the risk of pneumonia after chest infection is justifiable, particularly in elderly patients in whom the risk is highest.
This view is reiterated in an accompanying BMJ editorial by researchers at the University of Antwerp, who say that most infections can be managed by watchful waiting.
BMJ-British Medical Journal
Most antibiotic prescribing is in primary care, and most of it is for common respiratory tract infections. Guidelines advise against the routine use of antibiotics in patients with upper respiratory tract infection, sore throat, and ear infection, but do recommend them for pneumonia.
Although rates of antibiotic prescribing for acute respiratory infections in UK general practice declined by 45% between 1994 and 2000, in 2000 antibiotics were still prescribed to 67% of patients with respiratory infection, including over 90% of those with chest infection, 80% with ear infections, 60% with sore throat, and 47% with upper respiratory tract infections.
On the basis of the evidence in this BMJ study, there seems to be a substantial gap between evidence based guidance and general practitioners' prescribing behaviour, say the authors.
So, they identified 3.36 million episodes of respiratory tract infection recorded between 1991 and 2001 in the UK General Practice Research Database and determined whether complications were less common in people who were prescribed antibiotics than in those who were not.
Risk of serious complications in the month after diagnosis were recorded: mastoiditis (infection of the mastoid bone of the skull) after ear infection, quinsy (an abscess at the back of the throat) after sore throat, and pneumonia after upper respiratory tract infection and chest infection.
The number of patients needed to treat to prevent one complication was also recorded.
Serious complications were rare after upper respiratory tract infections, sore throat, and ear infection. Antibiotics reduced the risk, but over 4,000 courses were needed to prevent one complication.
In contrast, the risk of pneumonia after chest infection was high, particularly in elderly people, and was substantially reduced by antibiotic use. The number needed to treat to prevent one case of pneumonia was 39 for those aged 65 and over and between 96 and 119 in younger age groups.
The risks were not appreciably different in smokers, those with chronic respiratory disease, or those with cardiac disease.
The authors conclude that general practitioners should not base their prescribing for sore throat, ear infection, or upper respiratory tract infections on a fear of serious complications. However, antibiotic prescribing to reduce the risk of pneumonia after chest infection is justifiable, particularly in elderly patients in whom the risk is highest.
This view is reiterated in an accompanying BMJ editorial by researchers at the University of Antwerp, who say that most infections can be managed by watchful waiting.
BMJ-British Medical Journal
Respiratory Tract Current Events and Respiratory Tract News RSSNew evidence for homeopathy
Two new studies conclude that a review which claimed that homeopathy is just a placebo, published in The Lancet, was seriously flawed.
Merck's odanacatib increased BMD over 2 years at key fracture sites in Phase IIB study
Two-year data from a Phase IIB study of odanacatib (formerly MK-0822), an investigational, selective cathepsin-K inhibitor in development for the treatment of osteoporosis by Merck & Co., Inc., demonstrated dose- dependent increases in bone mineral density (BMD) at the total hip, lumbar spine and femoral neck fracture sites and decreased indices of bone resorption compared to placebo in postmenopausal women with low BMD.
Bacterial pneumonia caused most deaths in 1918 influenza pandemic
The majority of deaths during the influenza pandemic of 1918-1919 were not caused by the influenza virus acting alone, report researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
Adverse reactions to antibiotics send thousands of patients to the ER
Adverse events from antibiotics cause an estimated 142,000 emergency department visits per year in the United States, according to a study published in the September 15, 2008 issue of Clinical Infectious Diseases.
Canadian study of colds and kids: Positive safety results for ginseng extract
Positive findings of a safety study involving children and a highly touted botanical extract (COLD-fX) show promise for its future development for kids as a Canadian cold and flu remedy. The results appear in the August, 2008 issue of Pediatrics - the official journal of the American Academy of Pediatrics.
Warning for Teens: Teeth and Jewelry Don't Mix
TAU study finds that oral tissue piercings fracture teeth and increase dental complications in early adulthood
New test could aid children suffering from reflux disease
A nuclear medicine imaging test was used to confirm that children with respiratory problems may be more likely to develop gastroesophageal reflux disease, according to researchers at SNM's 55th Annual Meeting.
New analysis shows DAYTRANA offered ADHD symptom control for 12 months
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced findings from a new data analysis that was conducted to examine treatment differences with DAYTRAN (methylphenidate transdermal system) between boys and girls aged 6 to 12 years with Attention Deficit Hyperactivity Disorder (ADHD).
Young children hospitalized for flu associated with higher costs and higher risk illness
The high costs of hospitalizing young children for influenza creates a significant economic burden in the United States, underscoring the importance of preventive flu shots for children and the people with whom they have regular contact, according to research led by Cincinnati Children's Hospital Medical Center and presented May 4 at the Pediatric Academic Society annual meeting in Honolulu, Hawaii.
UIC scientists discover how some bacteria survive antibiotics
Researchers at the University of Illinois at Chicago have discovered how some bacteria can survive antibiotic treatment by turning on resistance mechanisms when exposed to the drugs. The findings, published in the April 24 issue of the journal Molecular Cell, could lead to more effective antibiotics to treat a variety of infections.
More Respiratory Tract Current Events and Respiratory Tract News Articles
 | Kendig's Disorders of the Respiratory Tract in Children (Disorders of the Respiratory Tract in Children (Kendig's)) by Victor Chernick, Thomas F. Boat, Robert W. Wilmott, Andrew Bush This definitive text on respiratory disease in children has been completely updated and revised for the 7th Edition. Several new chapters have been added, including information on the impact of environmental pollution on lung disease in children. Provides the most authoritative and comprehensive coverage available of basic science and clinical problems related to pediatric lung... |
 | Disorders of the Respiratory Tract: Common Challenges in Primary Care (Current Clinical Practice) by Matthew L. Mintz A concise review of the epidemiology, pathogenesis, and management of common respiratory conditions seen in a primary care setting. Using an illuminating case-based approach, Dr. Mintz assesses the key clinical questions that a primary care physician would ask and applies the most up-to-date research and guidelines to offer the practitioner evidence-based solutions. The author covers the range of... |
| Non-Neoplastic Disorders of the Lower Respiratory Tract (Atlas of Nontumor Pathology) by William D., M.D. Travis | |
| Stigmata of Respiratory Tract Allergies by Meyer B. Marks | |
 | RN Expert Guides: Respiratory Care (Rn Expert Guides) RN Expert Guide: Respiratory Care is presented in the quick-reference, easy-to-follow style that exemplifies all the RN Expert Guides. Also, as with other RN Expert Guides, explanations are clarified and enhanced by abundant illustrations and tables. This RN Expert Guide covers principles and practices of respiratory care, along with anatomy and physiology, assessment, diagnostic test... |
 | Pharmacology of the Respiratory Tract (Lung Biology in Health and Disease) by Chung Emphasizing state-of-the-art pharmacological approaches to controlling pathophysiological processes in the airway, this comprehensive reference provides clinicians and scientists with a review of the normal and abnormal physiological, biochemical, and molecular aspects of the respiratory tract.... |
 | Respiratory Nursing: A Core Curriculum By the 1990s, it became clear to many in the nursing community that certification for respiratory nursing practice was desirable, even necessary, but that this could not take place without a carefully designed CORE Curriculum. This book, nearly a decade in the making, sets out such a curriculum. Put together by an expert team of respiratory nurse practitioners, the book includes 42 chapters, each... |
 | Respiratory Care: A Guide to Clinical Practice Here is the classic respiratory text -- completely revised and updated for the fourth edition! Now featuring an even stronger clinical focus, this standard-setting reference reflects the latest research findings, therapies and equipment, providing the reader with the most up-to-date information available anywhere. The larger format of this latest edition reflects a wealth of changes.... |
| Stigmata of respiratory tract allergies (A scope publication) by Meyer B Marks | |
| Tumors of the lower respiratory tract (Atlas of tumor pathology) by Averill A Liebow |
| © 2008 BrightSurf.com |